Amplia Therapeutics Limited (INNMF)
OTCMKTS · Delayed Price · Currency is USD
0.0890
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

Amplia Therapeutics Balance Sheet

Millions AUD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
29.1610.863.399.2614.611.85
Cash & Short-Term Investments
29.1610.863.399.2614.611.85
Cash Growth
539.62%220.90%-63.43%-36.63%690.33%66.81%
Other Receivables
6.43.773.181.151.841
Receivables
6.43.773.181.151.841
Prepaid Expenses
0.130.110.070.040.030.05
Other Current Assets
0.40.180.120.070.050.04
Total Current Assets
36.0914.936.7510.5116.532.94
Property, Plant & Equipment
0.40.020.10.180.010.01
Other Intangible Assets
7.947.947.947.947.947.94
Other Long-Term Assets
0.110.050.050.05--
Total Assets
44.5422.9414.8518.6824.4810.88
Accounts Payable
1.121.561.60.350.370.49
Short-Term Debt
--1.492.11--
Current Portion of Leases
0.080.010.080.07--
Other Current Liabilities
0.080.310.230.220.160.05
Total Current Liabilities
1.281.893.42.750.530.54
Long-Term Debt
----2.1-
Long-Term Leases
0.3-0.010.09--
Other Long-Term Liabilities
0.030.020.0100.01-
Total Liabilities
1.611.913.432.852.640.54
Common Stock
193.43167.39151.53151.53151.51136.55
Retained Earnings
-149.48-145.54-139.01-134.72-128.62-125.21
Comprehensive Income & Other
-1.03-0.83-1.1-0.97-1.04-1.01
Shareholders' Equity
42.9321.0211.4215.8421.8510.34
Total Liabilities & Equity
44.5422.9414.8518.6824.4810.88
Total Debt
0.380.011.592.282.1-
Net Cash (Debt)
28.7810.851.86.9812.511.85
Net Cash Growth
538.96%503.17%-74.23%-44.19%576.70%66.81%
Net Cash Per Share
0.070.040.010.040.090.02
Filing Date Shares Outstanding
513.07387.95271.61194.01193.85107.97
Total Common Shares Outstanding
513.07387.95194.01194.01193.85107.97
Working Capital
34.8113.043.357.76162.4
Book Value Per Share
0.080.050.060.080.110.10
Tangible Book Value
34.9913.093.487.913.912.4
Tangible Book Value Per Share
0.070.030.020.040.070.02
Machinery
----0.020.01
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.